Aspira Women's Health Inc. (AWH)
NASDAQ: AWH · IEX Real-Time Price · USD
1.480
-0.010 (-0.67%)
At close: Jul 19, 2024, 4:00 PM
1.420
-0.060 (-4.05%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Aspira Women's Health Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 1997
Revenue
8.999.158.186.814.654.54
Upgrade
Revenue Growth (YoY)
4.46%11.85%20.14%46.46%2.49%48.64%
Upgrade
Cost of Revenue
3.73.893.863.753.423.34
Upgrade
Gross Profit
5.295.264.323.061.241.2
Upgrade
Selling, General & Admin
18.920.0829.5430.3417.1115.46
Upgrade
Research & Development
3.674.045.925.312.11.02
Upgrade
Operating Expenses
22.5724.1135.4635.6619.2216.47
Upgrade
Operating Income
-17.28-18.85-31.14-32.6-17.98-15.28
Upgrade
Interest Expense / Income
-0000.05-0.010
Upgrade
Other Expense / Income
-2.54-2.16-1.25-0.98-0.07-0.04
Upgrade
Pretax Income
-14.74-16.69-29.89-31.66-17.91-15.24
Upgrade
Net Income
-14.74-16.69-29.89-31.66-17.91-15.24
Upgrade
Shares Outstanding (Basic)
1298776
Upgrade
Shares Outstanding (Diluted)
1298776
Upgrade
Shares Change
42.50%18.85%4.79%10.41%16.31%23.56%
Upgrade
EPS (Basic)
-1.42-1.81-3.85-4.27-2.70-2.70
Upgrade
EPS (Diluted)
-1.42-1.81-3.85-4.27-2.70-2.70
Upgrade
Free Cash Flow
-14.66-15.92-31.3-27.58-15.22-13.1
Upgrade
Free Cash Flow Per Share
-1.24-1.72-4.03-3.72-2.27-2.27
Upgrade
Gross Margin
58.84%57.48%52.82%44.95%26.57%26.33%
Upgrade
Operating Margin
-192.21%-205.94%-380.47%-478.49%-386.61%-336.67%
Upgrade
Profit Margin
-163.95%-182.32%-365.16%-464.80%-384.97%-335.76%
Upgrade
Free Cash Flow Margin
-163.00%-173.89%-382.45%-404.86%-327.33%-288.63%
Upgrade
EBITDA
-14.6-16.5-29.62-31.28-17.62-14.9
Upgrade
EBITDA Margin
-162.37%-180.25%-361.89%-459.12%-378.93%-328.43%
Upgrade
Depreciation & Amortization
0.150.190.270.340.290.33
Upgrade
EBIT
-14.74-16.69-29.89-31.61-17.92-15.24
Upgrade
EBIT Margin
-163.99%-182.32%-365.16%-464.09%-385.19%-335.76%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).